Consensus Sopharma AD

Equities

SFA

BG11SOSOBT18

End-of-day quote Bulgaria S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
6 ^BGN	-0.66%		-0.99%	+4.90%

Feb. 29	Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023	CI

Evolution of the average Target Price on Sopharma AD

Price target over the last 5 years

History of analyst recommendation changes

4b2b22b574cb94f66598e8c7449d738.Xo0CyIYSAHLpbT61QEjLPdTXsBlccljFiRpP5bwEzBM.GudSv7NkWUWdIGzeH3yMC6WmiCgkQiCN22wIgvVyvFUJ6nKX7SV3K68Bcw~bdfebe1eaee053b309617d32465f0142

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6 BGN

Average target price

7.14 BGN

Spread / Average Target

+19.00%

High Price Target

7.14 BGN

Spread / Highest target

+19.00%

Low Price Target

7.14 BGN

Spread / Lowest Target

+19.00%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar